Advertisement World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market

CBDepot introduced the world’s first pharmaceutical GMP natural CBD isolate to the API segment during the world’s biggest pharmaceutical event, the CPhI in Frankfurt, in October 2017.

CBDepot’s work has been constantly driven by innovations. We have been bringing new isolated cannabinoids and new preparations for food and food supplement sectors, which tackle the Novel Food regulation on hemp derivatives in the EU.